During the past decade, Department of Psychiatry, Yale School of Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Psychiatry, Yale School of Medicine" #1 collaborator was "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "VU University of Amsterdam" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Department of Psychiatry, Yale School of Medicine" are "Schizophrenia" (3 trials), "Nicotine Dependence" (1 trials), "Opioid-Related Disorders" (1 trials), "Substance-Related Disorders" (1 trials) and "Tobacco Use Disorder" (1 trials). Many other conditions were trialed in "Department of Psychiatry, Yale School of Medicine" in a lesser frequency.

Most popular intervention types in "Department of Psychiatry, Yale School of Medicine" are "Behavioral" (3 trials), "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Magstim Rapid 2 system triggering Magstim Super Rapid system" (2 trials), "AAT-experiment" (1 trials), "AAT-placebo" (1 trials), "Flumazenil" (1 trials) and "Lofexidine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Psychiatry, Yale School of Medicine" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Psychiatry, Yale School of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Department of Psychiatry, Yale School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Psychiatry, Yale School of Medicine, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".